IDEX Corporation IEX
Composite 55/100; the shares have moved about 23% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 32/100 — a moderate mark against it.
Balance-sheet strength ranks 71/100 — a moderate point in its favour. Momentum ranks 65/100 — a moderate point in its favour. Quality ranks 61/100 — a slight point in its favour.
Valuation ranks 32/100 — a moderate mark against it. Growth ranks 45/100 — a slight mark against it. Income ranks 49/100 — a slight mark against it.
What the company does IDEX Corporation (IEX) designs and manufactures precision fluidics, pumps, valves, and sealing solutions across three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP).
Key financials IDEX reports ROE 13% and net margins 14.5%, with revenue growth 6% and EPS down -4%. Debt/equity is 0.47 and current ratio 3.05. Forward P/E is 26.81, EV/EBITDA 19.40, and dividend yield 1.3%.
Stock health Sideravia scores: Quality 61, Growth 48, Strength 71, Valuation 31, Momentum 73, Income 49. Piotroski F-Score is 7/9. 12-month momentum is 41%, RSI(14) 47.
Price vs fair value The stock trades at a **discount of 10.50%** versus the analyst mean target of 254.50. - Analysts remain cautiously optimistic on long-term positioning (Are Wall Street Analysts Predicting IDEX Stock Will Climb or Sink?). - Recent earnings commentary highlights modest post-report upside (Why Is Idex (IEX) Up 0.1% Since Last Earnings Report?).
Looking forward Forward PEG of 1.03 suggests valuation sensitivity to growth execution. Segment mix shift toward HST and FMT may drive margin expansion if demand stabilizes.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.